CHSCP
CHS INC
Nasdaq, Nasdaq, Nasdaq, Nasdaq, Nasdaq · CIK 823277
Last close26.2
Daily change+0.00 (0.00%)
10 Years gain+37.99%
Dividends TTM2 (+0.00%)
Dividend yield7.63%
Fundamental Analysis
CHSCP · STANDARD
SIC 5150 · Wholesale-Farm Product Raw Materials · Fiscal year end 0831
Fundamental
28.1Momentum
48.3Acceleration
47.0Confidence
95.0Annual Revenue16
Quarterly Revenue58
Annual CFO16
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth0.0 / 25
Quality13.7 / 25
Capital Efficiency0.2 / 20
Balance Sheet14.3 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 0.817 percentage points.
FCF turned positiveFree cash flow moved from negative to positive.
Net debt reductionNet debt declined versus the comparison period.
Key Metrics
Revenue Growth TTM-26.17%OK
Revenue CAGR 3Y-9.47%OK
Gross Margin5.02%OK
Operating Margin0.26%OK
FCF Margin1.64%OK
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC0.45%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFO-0.55xOK
Diluted Share Growth 1Yn/aINSUFFICIENT_HISTORY
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Aug 31, 2025 | $35.46B | $1.14B | $90.76M | $635.79M | -$92.79M | 3.21% | 0.26% | -0.26% | 0.73% | n/a |
| 2025 FY Aug 31, 2024 | $39.26B | $1.75B | $584.36M | $1.27B | $464.12M | 4.46% | 1.49% | 1.18% | 5.28% | n/a |
| 2025 FY Aug 31, 2023 | $45.59B | $2.38B | $1.34B | $3.28B | $2.72B | 5.21% | 2.95% | 5.97% | 12.09% | n/a |
| 2024 FY Aug 31, 2022 | $47.79B | $2.13B | $1.13B | $1.95B | $1.59B | 4.45% | 2.36% | 3.33% | 10.09% | n/a |
| 2023 FY Aug 31, 2021 | $38.45B | $951.40M | $205.80M | $757.81M | $440.02M | 2.47% | 0.54% | 1.14% | 1.85% | n/a |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $23.00B | sum latest 4 fiscal quarters Revenue | OK | 0000823277-26-000023, 0000823277-26-000006 |
| Revenue Growth TTM | -26.17% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0000823277-26-000023, 0000823277-26-000006 |
| Revenue CAGR 3Y | -9.47% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0000823277-25-000038 |
| Revenue CAGR 5Y | 4.54% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0000823277-25-000038 |
| Gross Profit CAGR 3Y | -18.85% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0000823277-25-000038 |
| Operating Income Growth | -68.23% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0000823277-26-000023, 0000823277-26-000006 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | 0000823277-26-000023, 0000823277-26-000016 |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 5.02% | Gross Profit / Revenue | OK | 0000823277-26-000023, 0000823277-26-000006 |
| Operating Margin | 0.26% | Operating Income / Revenue | OK | 0000823277-26-000023, 0000823277-26-000006 |
| FCF Margin | 1.64% | (CFO - CapEx) / Revenue | OK | 0000823277-26-000023, 0000823277-26-000016 |
| CFO / Net Income | 1.46x | CFO / Net Income | OK | 0000823277-26-000023, 0000823277-26-000016 |
| FCF / Net Income | 0.62x | FCF / Net Income | OK | 0000823277-26-000023, 0000823277-26-000016 |
| ROIC | 0.45% | NOPAT / Average Invested Capital | OK | 0000823277-26-000023, 0000823277-26-000006 |
| Net Debt / CFO | -0.55x | Net Debt / CFO | OK | 0000823277-26-000023, 0000823277-26-000016 |